Although LCNEC tumors have been shown to strongly express receptor tyrosine kinases such as KIT, PDGFRA, PDGFRB and MET, compared to other NSCLC groups, there is less support of mutations being the underlying cause for the elevated expression [4, 18]. This evidence concerns the gene PDGFRA and large cell neuroendocrine carcinoma.